Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01894607 · ClinicalTrials.gov registry record · NA
Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01894607: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT01894607 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01894607, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The goal of this clinical research is to learn how effective an ultrasound contrast agent, called DEFINITY, is when used during ultrasound-guided surgery to remove part of one or both kidneys.
Interventions
- BEHAVIORAL Phone Call
- DRUG DEFINITY
- PROCEDURE Contrast Enhanced Intraoperative Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01894607
The ClinicalTrials.gov registry entry for NCT01894607 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Phone Call is the first listed.
NCT01894607 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01894607 about?
NCT01894607 is a clinical study titled "Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy". The goal of this clinical research is to learn how effective an ultrasound contrast agent, called DEFINITY, is when used during ultrasound-guided surgery to remove part of one or both kidneys.
What is the current status of trial NCT01894607?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2013-10.
What interventions are being tested in trial NCT01894607?
The interventions under investigation include: Phone Call (BEHAVIORAL), DEFINITY (DRUG), Contrast Enhanced Intraoperative Ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT01894607?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.